본문 바로가기
KERD
논문KCI 등재

Psychotic Features as the First Manifestation of 22q11.2 Deletion Syndrome

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

The 22q11.2 deletion is a genetic disorder which is characterized by abnormalities in cardiac functioning, facial structure, neurobehavioral development, T cell functioning, and velopharyngeal insufficiencies. In the presented case study, 22q11.2 deletion was found in a patient who has psychotic symptoms only. A 25-year-old woman with a history of hypoparathyroidism and hypothyroidism presented with auditory hallucinations and persecutory delusions. After three months of treatment with antipsychotic medications, the patient was readmitted with generalized tonic-clonic seizures. The following week, the patient went into sepsis. A fluorescent in situ hybridization (FISH) analysis revealed the presence of a 22q11.2 microdeletion. This case study suggests that psychotic symptoms can develop prior to the typical symptoms of a 22q11.2 deletion. As such, psychiatrists should test for genetic abnormalities in patients with schizophrenia when these patients present with seizures and immunodeficiencies.

Abstract

The 22q11.2 deletion is a genetic disorder which is characterized by abnormalities in cardiac functioning, facial structure, neurobehavioral development, T cell functioning, and velopharyngeal insufficiencies. In the presented case study, 22q11.2 deletion was found in a patient who has psychotic symptoms only. A 25-year-old woman with a history of hypoparathyroidism and hypothyroidism presented with auditory hallucinations and persecutory delusions. After three months of treatment with antipsychotic medications, the patient was readmitted with generalized tonic-clonic seizures. The following week, the patient went into sepsis. A fluorescent in situ hybridization (FISH) analysis revealed the presence of a 22q11.2 microdeletion. This case study suggests that psychotic symptoms can develop prior to the typical symptoms of a 22q11.2 deletion. As such, psychiatrists should test for genetic abnormalities in patients with schizophrenia when these patients present with seizures and immunodeficiencies.

참고문헌 (18)

  1. Pulver AE, "Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives", J Nerv Ment Dis, 182, pp.476~478 (1994)
  2. Murphy KC, "High rates of schizophrenia in adults with velo-cardio-facial syndrome", Arch Gen Psychiatry, 56, pp.940~945 (1999)
  3. Roubertie A, "Neurological presentation of three patients with 22q 11 deletion (CATCH 22 syndrome)", Brain Dev, 23, pp.810~814 (2001)
  4. Shprintzen RJ, "Lateonset psychosis in the velo-cardio-facial syndrome", Am J Med Genet, 42, pp.141~142 (1992)
  5. Gothelf D, "Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome", Dev Disabil Res Rev, 14, pp.59~68 (2008)
  6. Karayiorgou M, "Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11", Proc Natl Acad Sci U S A, 92, pp.7612~7616 (1995)
  7. Wiehahn GJ, "Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients", Am J Med Genet B Neuropsychiatr Genet, 129B, pp.20~22 (2004)
  8. Sporn A, "22q11 deletion syndrome in childhood onset schizophrenia: an update", Mol Psychiatry, 9, pp.225~226 (2004)
  9. Arinami T, "Screening for 22q11 deletions in a schizophrenia population", Schizophr Res, 52, pp.167~170 (2001)
  10. Ivanov D, "Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis. Molecular genetic study", Br J Psychiatry, 183, pp.409~413 (2003)
  11. Horowitz A, "A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients", Schizophr Res, 73, pp.263~267 (2005)
  12. Hoogendoorn ML, "Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia", Schizophr Res, 98, pp.84~88 (2008)
  13. Prasad SE, "Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome", Dev Disabil Res Rev, 14, pp.26~34 (2008)
  14. Kao A, "Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion", Am J Med Genet A, 129A, pp.29~34 (2004)
  15. Tonelli AR, "Seizures as the first manifestation of chromosome 22q11.2 deletion syndrome in a 40-year old man: a case report", J Med Case Reports, 1, pp.167~ (2007)
  16. Pisani F, "Effects of psychotropic drugs on seizure threshold", Drug Saf, 25, pp.91~110 (2002)
  17. Gonzalez-Heydrich J, "No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series", J Child Adolesc Psychopharmacol, 14, pp.295~310 (2004)
  18. SooYoungBhang, "22q11 Deletion Syndrome을 동반한 정신분열병 1예", 신경정신의학, 42(4) (2003), 대한신경정신의학회

관련 논문AI추천

Various Psychiatric Manifestation in DiGeorge Syndrome (22q11.2 Deletion Syndrome): A Case Report서화규, Byung Dae Lee, Eun Soo Moon, Giok Kim, Hee Jeong Jeong, Je Min Park, Kang Yoon Lee, Soo Yeon Kim, Young Min Lee대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2020 · 제18권 제3호Psychiatric Comorbidities in Adults with DiGeorge SyndromeAalamgeer Ibrahim, Chintan Trivedi, Hiren Patel, Jigar Patel, Kanwarjeet Singh Brar, Muhammad Khalid Zafar, Ramu Vadukapuram, Uzma Beg, Zeeshan Mansuri대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제3호Epilepsy and Other Neuropsychiatric Manifestations in Children and Adolescents with 22q11.2 Deletion Syndrome고태성, 김구환, 김은희, 김효원, 염미선, 유한욱, 이범희, 이현정대한신경과학회 · Journal of Clinical Neurology2016 · 제12권 제1호Important Consideration in Choosing Antipsychotics in the Treatment of Patients with 22q11.2 Deletion Syndrome: Risk of Convulsion김원형, 최서현, Hee-Yeon Kim, Hye-Young Kim, Jae Nam Bae, Jung-Sub Lee, Sang-Gu Kang대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2020 · 제18권 제3호양측 줄무늬창백치아핵 석회화증으로 발현된 염색체22q11.2결손증후군권영남, 권용철, 이동환, 이상화, 장대일, 정유진, 허성혁대한신경과학회 · 대한신경과학회지2012 · 제30권 제4호Delayed diagnosis of 22q11 deletion syndrome due to late onset hypocalcemia in a 11-year-old girl with imperforated anus권은별, 김해중, 유동윤, 유은경, 조기현대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2017 · 제22권 제2호

이 간행물의 다른 논문 (8건)